Omalizumab in chronic spontaneous urticaria patients...

  • Main
  • 2018 / 06
  • Omalizumab in chronic spontaneous urticaria patients...
British Journal of Dermatology 2018 / 06

Omalizumab in chronic spontaneous urticaria patients nonresponsive to H1-antihistamine treatment: Results of the phase IV open-label SUNRISE study

Bérard, F., Ferrier le Bouëdec, M. C., Bouillet, L., Reguiai, Z., Barbaud, A., Cambazard, F., Milpied, B., Pelvet, B., Kasujee, I., Gharbi, H., Lacour, J. P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
British Journal of Dermatology
DOI:
10.1111/bjd.16904
Date:
June, 2018
File:
PDF, 660 KB
english, 2018
Conversion to is in progress
Conversion to is failed